
A pinch of salt - A podcast by ERA
European Renal Association 129 episodes Nov 12, 2026
A pinch of salt is the official ERA podcast dedicated to nephrology. Each month, three episodes are released featuring discussions with nephrologists and other physicians about advances in clinical practice and renal medicine. The podcast is hosted by Andrej Skoberne and George Kosmadakis.
Episodes

#87 Ten tips on how to manage obesity in the presence of CKD, with Pierre Delanaye (Host) and Nadine Kaesler (Guest)
Pierre Delanaye, host of this episode, welcomes Nadine Kaesler, co-author of the paper “Ten tips on how to manage obesity in the presence of CKD” published in Clinical Kidney Journal, to discuss the challenges of managing obesity in patients with chronic kidney disease.Discover the key challenges and clinical considerations surrounding obesity management in CKD, and read the full paper for further

#86 Antibody-mediated rejection—treatment standard, with Rainer Oberbauer (Host) and Georg A. Böhmig (Guest)
Rainer Oberbauer is the host of this episode, welcoming Georg A. Böhmig, co-author of the paper “Antibody-mediated rejection—treatment standard” published in the Nephrology Dialysis Transplantation, to discuss the challenges and evolving therapeutic strategies in antibody-mediated rejection (AMR) after kidney transplantation.Discover more about the topic in this episode and explore the full paper

#85 Top ten tips in managing ANCA vasculitis, with Ana Carina Ferreira (Host) and Min Hui Tan (Guest)
In this episode, Ana Carina Ferreira takes on the role of host, welcoming Min Hui Tan, co-author of the paper “Top Ten Tips in Managing ANCA Vasculitis” published in the Clinical Kidney Journal, to discuss key challenges and evolving strategies in the management of ANCA-associated vasculitis.Tune in for an insightful discussion and read the full article!Min Hui Tan, David Jayne, Top ten tips in ma

#84 The failing allograft: more than the rise of creatinine with Annelies de Weerd
We watch creatinine rise and fall all the time, but a failing kidney allograft is more than a numbers game. Annelies de Weerd (Erasmus MC Rotterdam) covers when to call it failure, the immunosuppression taper, and helping patients through what feels like a step backwards.

#83 CKM syndrome: why you should care, with Amaryllis Van Craenenbroeck
Heart over there, kidney over here, metabolism somebody else’s problem? Not anymore. Amaryllis Van Craenenbroeck (KU Leuven) makes the case for Cardiovascular-Kidney-Metabolic syndrome as one continuum, not three separated clinics. Four drug classes, three organs, one patient, prevention upstream, and a fair hearing for the sceptics who call it disease-mongering.

#82 POCUS in nephrology: ready for prime time? with Faeq Husain-Syed
For decades, “volume status” meant a (un)healthy dose of educated guessing. What if you could just look? Faeq Husain-Syed (Giessen) joins "A pinch of salt" to explain how kidney venous Doppler makes congestion visible, and whether Point-of-care Ultrasound is ready for prime time.

Trailer POCUS in Nephrology: ready for prime time?, CKM syndrome: why you should care, The failing allograft: more than the rise of creatinine

#81 Diuretics in Acute Heart Failure: take them with a “pinch of salt”? with Jozene Ter Maaten
In acute heart failure, we’re told to take things with a pinch of salt but salt might be exactly what we should watch. Hugo Diniz welcomes Jozine ter Maaten, the principal investigator behind the PUSH-AHF trial, to argue heart failure is a sodium problem dressed as a fluid one — and why a rising creatinine may be a friend, not a foe.

#80 European Specialty Examination in Nephrology: demystifying the ESENeph with David Lappin
Every nephrology trainee in Europe has heard about it, stressed about it, or is quietly pretending it doesn’t exist: the ESENeph. Is it a genuine European passport, or just one more exam? Hugo Diniz talks to David Lappin, about the exam’s format, its career value, and why trainees should sign up.

#79 Osteoporosis in CKD: when bone and kidneys disagree? with Hanne Skou Jørgensen
We obsess over PTH, calcium, and phosphate — yet our patients are quietly, inconveniently, fracturing. Hip fracture rates in dialysis patients dwarf the general population, and with very high mortality rates. Hugo Diniz asks Hanne Skou Jørgensen the uncomfortable question: have nephrologists been missing osteoporosis all along? DEXA’s comeback, bone turnover markers, and a practical screening algo

Trailer Osteoporosis in CKD: when bone and kidneys disagree?, European Specialty Examination in Nephrology: demystifying the ESENeph and Diuretics in Acute Heart Failure: take them with a “pinch of salt”?

#78 B-cell therapy in IgA Nephropathy: worth the hype? with Vlado Perkovic
For decades, treating IgA nephropathy meant looking thoughtful while saying "let's optimise supportive care and monitor closely." Not anymore. We've gone from one road to a full therapeutic roundabout, and nobody wants the wrong exit. Hugo Diniz welcomes Vlado Perkovic to navigate the new era: anti-APRIL and anti-BAFF agents, the VISIONARY and ORIGIN data, and the 2025 KDIGO fr











